Abstract |
The cardiovascular effects of AR-C 239, a new and selective alpha 1-adrenoceptor blocking drug were studied in normotensive and spontaneously hypertensive rats (SHR). AR-C 239 (300 micrograms/kg i.v.) did not change the heart rate in control (without pretreatment) and bilaterally vagotomized normotensive rats, but induced significant bradycardia in rats pretreated with a beta- adrenoceptor blocking drug. This bradycardic effect was inhibited by atropine or bilateral vagotomy. In SHR, the administration of AR-C 239 reduced heart rate in the control, bilaterally vagotomized and beta-blocked rats. Blood pressure was decreased in the same way in the two rat strains. It is suggested that central alpha 1-adrenoceptors could participate in the control of vagal tone in normotensive and SH rats, and of sympathetic activity in the SHR only.
|
Authors | A M Huchet, M F Doursout, J Chelly, H Schmitt |
Journal | European journal of pharmacology
(Eur J Pharmacol)
Vol. 85
Issue 2
Pg. 239-42
(Nov 19 1982)
ISSN: 0014-2999 [Print] Netherlands |
PMID | 6129986
(Publication Type: Journal Article)
|
Chemical References |
- Adrenergic alpha-Antagonists
- Isoquinolines
- Piperazines
- Receptors, Adrenergic
- Receptors, Adrenergic, alpha
- AR-C239
|
Topics |
- Adrenergic alpha-Antagonists
(pharmacology)
- Animals
- Autonomic Nervous System
(physiopathology)
- Blood Pressure
- Heart Rate
- Hypertension
(physiopathology)
- Isoquinolines
(pharmacology)
- Male
- Piperazines
- Rats
- Rats, Inbred Strains
- Receptors, Adrenergic
(physiology)
- Receptors, Adrenergic, alpha
(physiology)
|